Bone biologics prices $5,100,000 million underwritten public offering

Burlington, mass.--(business wire)--bone biologics corporation (nasdaq: bblg), a developer of orthobiologic products for spine fusion markets, announces the pricing of an underwritten public offering of 3,777,778 units of securities at an offering price of $1.35 per unit, for total gross proceeds of $5,100,000 million, before deducting underwriting discounts and commissions and other estimated offering expenses. each unit consists of: (i) one share of common stock; (ii) one series a warrant to
BBLG Ratings Summary
BBLG Quant Ranking